Upregulation of K2P5.1 potassium channels in multiple sclerosis

Annals of Neurology

Volumn 68, Issue 1, 2010, Pages 58-69

  Bittner, Stefan ^a   Bobak, Nicole ^a,b   Herrmann, Alexander M ^a,b   Göbel, Kerstin ^a,b   Meuth, Patrick ^b   Höhn, Karin G ^a   Stenner, Max Philipp ^a   Budde, Thomas ^b   Wiendl, Heinz ^a,b   Meuth, Sven G ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; POTASSIUM CHANNEL; POTASSIUM CHANNEL K2P5.1; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CD3 ANTIGEN; KCNK5 PROTEIN, HUMAN; POTASSIUM CHANNEL BLOCKING AGENT; TANDEM PORE DOMAIN POTASSIUM CHANNEL;

ARTICLE; BRAIN TISSUE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL STIMULATION; CEREBROSPINAL FLUID; COMPUTER MODEL; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; UPREGULATION; BRAIN; CELL LINE; CELL MEMBRANE POTENTIAL; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; MONONUCLEAR CELL; PATHOPHYSIOLOGY; PHYSIOLOGY; T LYMPHOCYTE;

ANTIGENS, CD3; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CEREBROSPINAL FLUID; HUMANS; LEUKOCYTES, MONONUCLEAR; MEMBRANE POTENTIALS; MULTIPLE SCLEROSIS; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS, TANDEM PORE DOMAIN; RNA, MESSENGER; T-LYMPHOCYTES; UP-REGULATION;

EID: 77954080093     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22010     Document Type: Article

References (37)

1. Allegretta M, Nicklas JA, Sriram S, Albertini RJ. T cells responsive to myelin basic protein in patients with multiple sclerosis. Science 1990;247:718-721. (Pubitemid 20054942)
2. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005;23:683-747.
3. Wekerle H, Kojima K, Lannes-Vieira J, et al. Animal models. Ann Neurol 1994;36(suppl):S47-S53.
4. Gold R, Linington C, Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006;129:1953-1971. (Pubitemid 44289062)
5. Goldstein SA, Bockenhauer D, O'Kelly I, Zilberberg N. Potassium leak channels and the KCNK family of two-P-domain subunits. Nat Rev Neurosci 2001;2:175-184. (Pubitemid 33673370)
6. Reyes R, Duprat F, Lesage F, et al. Cloning and expression of a novel pH-sensitive two pore domain K+ channel from human kidney. J Biol Chem 1998;273:30863-30869. (Pubitemid 28533086)
7. Meuth SG, Budde T, Kanyshkova T, et al. Contribution of TWIK-related acid-sensitive K+ channel 1 (TASK1) and TASK3 channels to the control of activity modes in thalamocortical neurons. J Neurosci 2003;23:6460-6469. (Pubitemid 36909871)
8. Beeton C, Wulff H, Standifer NE, et al. Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci U S A 2006;103:17414-17419.
9. Judge SI, Lee JM, Bever CT Jr, Hoffman PM. Voltage-gated potassium channels in multiple sclerosis: overview and new implications for treatment of central nervous system inflammation and degeneration. J Rehabil Res Dev 2006;43:111-122.
10. Ghanshani S, Wulff H, Miller MJ, et al. Up-regulation of the IKCa1 potassium channel during T-cell activation. Molecular mechanism and functional consequences. J Biol Chem 2000;275: 37137-37149.
11. Meuth SG, Bittner S, Meuth P, et al. TWIK-related acid-sensitive K+ channel 1 (TASK1) and TASK3 critically influence T lymphocyte effector functions. J Biol Chem 2008;283:14559-14570.
12. Pottosin II, Bonales-Alatorre E, Valencia-Cruz G, et al. TRESK-like potassium channels in leukemic T cells. Pflugers Arch 2008;456: 1037-1048.
13. Valencia-Cruz G, Shabala L, Delgado-Enciso I, et al. K(bg) and Kv1.3 channels mediate potassium efflux in the early phase of apoptosis in Jurkat T lymphocytes. Am J Physiol Cell Physiol 2009;297:C1544-C1553.
14. Morton MJ, Abohamed A, Sivaprasadarao A, Hunter M. pH sensing in the two-pore domain K+ channel, TASK2. Proc Natl Acad Sci U S A 2005;102:16102- 16106.
15. Niemeyer MI, Gonzalez-Nilo FD, Zuniga L, et al. Neutralization of a single arginine residue gates open a two-pore domain, alkalia-ctivated K+ channel. Proc Natl Acad Sci U S A 2007;104: 666-671.
16. Meuth SG, Herrmann AM, Ip CW, et al. The two-pore domain potassium channel TASK3 functionally impacts glioma cell death. J Neurooncol 2008;87:263-270.
17. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria." Ann Neurol 2005;58:840-846.
18. Dixon W, Massey F. Introduction to statistical analysis. New York, NY: McGraw-Hill, 1969.
19. Wulff H, Zhorov BS. K+ channel modulators for the treatment of neurological disorders and autoimmune diseases. Chem Rev 2008;108:1744-1773.
20. Rus H, Pardo CA, Hu L, et al. The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain. Proc Natl Acad Sci U S A 2005;102: 11094-11099.
21. Nicolaou SA, Szigligeti P, Neumeier L, et al. Altered dynamics of Kv1.3 channel compartmentalization in the immunological synapse in systemic lupus erythematosus. J Immunol 2007;179: 346-356. (Pubitemid 46986551)
22. Wulff H, Miller MJ, Hansel W, et al. Design of a potent and selective inhibitor of the intermediate-conductance Ca2+-activated K+ channel, IKCa1: a potential immunosuppressant. Proc Natl Acad Sci U S A 2000;97:8151-8156.
23. Warth R, Barriere H, Meneton P, et al. Proximal renal tubular acidosis in TASK2 K+ channel-deficient mice reveals a mechanism for stabilizing bicarbonate transport. Proc Natl Acad Sci U S A 2004;101:8215-8220.
24. Gabriel A, Abdallah M, Yost CS, et al. Localization of the tandem pore domain K+ channel KCNK5 (TASK-2) in the rat central nervous system. Brain Res Mol Brain Res 2002;98:153-163. (Pubitemid 34142291)
25. Hu L, Pennington M, Jiang Q, et al. Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes. J Immunol 2007;179: 4563-4570.
26. Zozulya AL, Wiendl H. The role of CD8 suppressors versus destructors in autoimmune central nervous system inflammation. Hum Immunol 2008;69:797-804.
27. Friese MA, Fugger L. Autoreactive CD8+ T cells in multiple sclerosis: a new target for therapy? Brain 2005;128:1747-1763.
28. Cabarrocas J, Bauer J, Piaggio E, et al. Effective and selective immune surveillance of the brain by MHC class I-restricted cytotoxic T lymphocytes. Eur J Immunol 2003;33:1174-1182. (Pubitemid 36609135)
29. Medana IM, Gallimore A, Oxenius A, et al. MHC class I-restricted killing of neurons by virus-specific CD8+ T lymphocytes is effected through the Fas/FasL, but not the perforin pathway. Eur J Immunol 2000;30:3623-3633. (Pubitemid 32005236)
30. Babbe H, Roers A, Waisman A, et al. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J Exp Med 2000;192:393-404.
31. Skulina C, Schmidt S, Dornmair K, et al. Multiple sclerosis: brain-infiltrating CD8+ T cells persist as clonal expansions in the cerebrospinal fluid and blood. Proc Natl Acad Sci U S A 2004;101: 2428-2433.
32. Zang YC, Li S, Rivera VM, et al. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis. J Immunol 2004;172:5120-5127.
33. Killestein J, Eikelenboom MJ, Izeboud T, et al. Cytokine producing CD8+ T cells are correlated to MRI features of tissue destruction in MS. J Neuroimmunol 2003;142:141-148.
34. Goldstein SA, Bayliss DA, Kim D, et al. International Union of Pharmacology. LV. Nomenclature and molecular relationships of two-P potassium channels. Pharmacol Rev 2005;57:527-540.
35. Alexander SP, Mathie A, Peters JA. Guide to receptors and channels (GRAC). 3rd ed. Br J Pharmacol 2008;153(suppl 2): S1-S209.
36. Feliciangeli S, Tardy MP, Sandoz G, et al. Potassium channel silencing by constitutive endocytosis and intracellular sequestration. J Biol Chem 2010;285:4798-4805.
37. Melzer N, Meuth SG, Wiendl H. CD8+ T cells and neuronal damage: direct and collateral mechanisms of cytotoxicity and impaired electrical excitability. FASEB J 2009;23:3659-3673.